Background: Mutations in CACNA1A, encoding a neuronal calcium channel subunit, and ATP1A2, encoding a catalytic subunit of a sodium-potassium-ATPase, have been found in some families with dominantly inherited hemiplegic migraine.
Objective: To determine the prevalence of mutations in these genes in individuals with different migraine syndromes.
Design: Prospective screening study.
Setting: University outpatient neurology clinic. Subjects Probands of 19 families with hemiplegic migraine, 7 with basilar migraine, 25 with migraine without aura, and 18 with migraine with aura, as well as 40 unaffected relatives of probands.
Interventions: All known exons and flanking introns of CACNA1A and ATP1A2 were subjected to denaturing high-performance liquid chromatography analysis of polymerase chain reaction-amplified genomic DNA. Exons with atypical elution patterns were sequenced by standard techniques.
Main Outcome Measures: Presence of mutations in CACNA1A and ATP1A2.
Results: A single mutation (T666M) was found in CACNA1A in a patient with hemiplegic migraine and ataxia. No other mutation was identified in either gene. The frequency of a previously reported intronic insertion in ATP1A2 was not significantly different between patients with migraine and control subjects.
Conclusion: These 2 genes are not associated with more common migraine syndromes and are not the most common hemiplegic migraine genes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/archneur.61.6.926 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A structural analysis of the splice-specific functional impact of the pathogenic familial hemiplegic migraine type 1 S218L mutation on Ca2.1 P/Q-type channel gating.
Mol Brain
November 2024
Michael Smith Laboratories, University of British Columbia, 2185 East Mall, Vancouver, BC, V6T 1Z4, Canada.
P/Q-type (Ca2.1) calcium channels mediate Ca influx essential for neuronal excitability and synaptic transmission. The CACNA1A gene, encoding the Ca2.
View Article and Find Full Text PDFVoltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies.
Cells
October 2024
Institut de Recherches Servier, Rue Francis Perrin, 91190 Gif-sur-Yvette, France.
Developmental and Epileptic Encephalopathies (DEEs) represent a clinically and genetically heterogeneous group of rare and severe epilepsies. DEEs commonly begin early in infancy with frequent seizures of various types associated with intellectual disability and leading to a neurodevelopmental delay or regression. Disease-causing genomic variants have been identified in numerous genes and are implicated in over 100 types of DEEs.
View Article and Find Full Text PDFIntellectual Disability in Episodic Ataxia Type 2: Beyond Paroxysmal Vertigo and Ataxia.
J Clin Neurol
November 2024
Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Korea.
Article Synopsis
- Episodic ataxia type 2 (EA2) is a genetic disorder causing dizziness and coordination issues, linked to mutations in the calcium channel gene; this study focused on assessing intellectual abilities in affected individuals.
- Researchers evaluated 13 patients in South Korea using the Wechsler Intelligence Scales and found that most had below-average IQ scores, with significant cognitive deficits across multiple areas.
- The findings suggest that individuals with EA2 may experience hidden intellectual disabilities unrelated to epilepsy; therefore, early diagnosis and management are crucial to prevent further brain function decline and may benefit from genetic counseling.
Neurological and Systemic Pitfalls in the Diagnosis of Cluster Headaches: A Case-Based Review.
Curr Neurol Neurosci Rep
December 2024
Department of Neurology, Vivekananda Institute of Medical Science, Kolkata, West Bengal, India.
Article Synopsis
- The review highlights common mistakes in diagnosing primary cluster headaches (CHs) using seven case examples to illustrate these pitfalls.
- Recent findings suggest that while CHs and migraines share some similarities, such as genetic factors and autonomic features, they also have distinct characteristics that can aid in differentiation.
- Key clinical features, such as restlessness during attacks, are crucial for diagnosing CHs and distinguishing them from other headache disorders, particularly within the group of Trigeminal Autonomic Cephalalgias (TACs).
Efficacy of galcanezumab in proline-rich transmembrane protein 2 (PRRT2)-associated familial hemiplegic migraine: A case series.
Headache
September 2024
Neurology Section, Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy.
Background: Familial hemiplegic migraine (FHM) is a rare subtype of migraine with aura. Variants in calcium voltage-gated channel subunit alpha1 A (CACNA1A), ATPase Na+/K+ transporting subunit alpha 2 (ATP1A2), and sodium voltage-gated channel alpha subunit 1 (SCN1A) genes have a well-established association with the development of FHM. Recent studies suggest that other genes may also have a significant role in the pathogenesis of FHM, including proline-rich transmembrane protein 2 (PRRT2).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!